MARCHF5 and cardiac hypertrophy: To further confirm whether in vivo overexpression of MARCH5 exacerbates myocardial hypertrophy, we utilised adeno‐associated virus (AAV9) vectors engineered to express MARCH5 (AAV9‐EGFP‐MARCH5‐flag) specifically in cardiomyocytes.